The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...
There are three different COVID vaccines to choose from this season: two mRNA vaccines from Pfizer and Moderna ... time that ...
GSK has reported positive interim results from its Phase II trial of mRNA-based multivalent influenza vaccine candidate, ...
Mater Research in Brisbane, Australia, has commenced a clinical trial for a new combined Covid-19 and flu vaccine from ...
The project — in collaboration with Erasmus University in the Netherlands — is supported by a recent $7 million grant from ...
A first-of-its-kind combined Covid-19 and influenza vaccine is being trialled by Queensland scientists in the hope it will ...
The most important thing to know is that the COVID vaccine is safe and effective, says Dr. Watkins. With that said, side effects from the COVID vaccine are rare, says Dr. Cennimo, and they usually ...
More than 90 clinical trials are now underway to develop mRNA vaccines for a broad range of infectious diseases, such as cytomegalovirus (CMV), human immunodeficiency virus (HIV), influenza ...